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Summary

Background Incomplete vital registration systems mean that causes of death during pregnancy and childbirth are
poorly understood in low-income and middle-income countries. To inform global efforts to reduce maternal mortality,
we compared physician review and computerised analysis of verbal autopsies (interpreting verbal autopsies [InterVA]
software), to understand their agreement on maternal cause of death and circumstances of mortality categories
(COMCATs) in the Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials.
Methods The CLIP trials took place in India, Pakistan, and Mozambique, enrolling pregnant women aged 12–49 years
between Nov 1, 2014, and Feb 28, 2017. 69 330 pregnant women were enrolled in 44 clusters (36 008 in the
22 intervention clusters and 33 322 in the 22 control clusters). In this secondary analysis of maternal deaths in CLIP,
we included women who died in any of the 22 intervention clusters or 22 control clusters. Trained staff administered
the WHO 2012 verbal autopsy after maternal deaths. Two physicians (and a third for consensus, if needed) reviewed
trial surveillance data and verbal autopsies, and, in intervention clusters, community health worker-led visit data.
They determined cause of death according to the WHO International Classification of Diseases-Maternal Mortality
(ICD-MM). Verbal autopsies were also analysed by InterVA computer models (versions 4 and 5) to generate cause of
death. COMCAT analysis was provided by InterVA-5 and, in India, by physician review of Maternal Newborn Health
Registry data. Causes of death and COMCATs assigned by physician review, Inter-VA-4, and InterVA-5 were compared,
with agreement assessed with Cohen’s κ coefficient.
Findings Of 61 988 pregnancies with successful follow-up in the CLIP trials, 143 maternal deaths were reported
(16 deaths in India, 105 in Pakistan, and 22 in Mozambique). The maternal death rate was 231 (95% CI 193–268) per
100 000 identified pregnancies. Most deaths were attributed to direct maternal causes (rather than indirect or
undetermined causes as per ICD-MM classification), with fair to good agreement between physician review and
InterVA-4 (κ=0·56 [95% CI 0·43–0·66]) or InterVA-5 (κ=0·44 [0·30–0·57]), and InterVA-4 and InterVA-5 (κ=0·72
[0·60–0·84]). The top three causes of death were the same by physician review, InterVA-4, and InterVA-5 (ICD-MM
categories obstetric haemorrhage, non-obstetric complications, and hypertensive disorders); however, attribution of
individual patient deaths to obstetric haemorrhage varied more between methods (physician review, 38 [27%]
deaths; InterVA-4, 69 [48%] deaths; and InterVA-5, 82 [57%] deaths), than did attribution to non-obstetric causes
(physician review, 39 [27%] deaths; InterVA-4, 37 [26%] deaths; and InterVA-5, 28 [20%] deaths) or hypertensive
disorders (physician review, 23 [16%] deaths; InterVA-4, 25 [17%] deaths; and InterVA-5, 24 [17%] deaths).
Agreement for all nine ICD-MM categories was fair for physician review versus InterVA-4 (κ=0·48 [0·38–0·58]),
poor for physician review versus InterVA-5 (κ=0·36 [0·27–0·46]), and good for InterVA-4 versus InterVA-5 (κ=0·69
[0·59–0·79]). The most commonly assigned COMCATs by InterVA-5 were emergencies (68 [48%] of 143 deaths)
and health systems (62 [43%] deaths), and by physician review (India only) were health systems (seven [44%] of
16 deaths) and inevitability (five [31%] deaths); agreement between InterVA-5 and physician review (India data only)
was poor (κ=0·04 [0·00–0·15]).
Interpretation Our findings indicate that InterVA-5 is less accurate than InterVA-4 at ascertaining causes and
circumstances of maternal death, when compared with physician review. Our results suggest a need to improve the
next iteration of InterVA, and for researchers and clinicians to preferentially use InterVA-4 when recording maternal
deaths.
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Research in context
Evidence before this study
Based on our use of the 2012 WHO verbal autopsy and the
publication date of the interpreting verbal autopsy model,
version 4 (InterVA-4), we searched PubMed from Jan 1, 2012,
to March 31, 2020 (updated on Oct 15, 2020), for publications
on “maternal death” OR “maternal mortality” AND “verbal
autopsy” AND “InterVA-4” OR “InterVA-5” OR “physician
review”. We limited our search to publications in English. We
identified that, for maternal deaths, agreement on cause of
death between physician review and computerised analysis of
verbal autopsies with InterVA-4 has often, but not uniformly,
been reported to be high, but usually with use of facility
records, introducing a high risk of bias compared with
population-level data.
Added value of this study
To our knowledge, this study is the first to specifically compare
physician review with the InterVA-4 and InterVA-5 models for
assignment of maternal cause of death. We also included the
novel circumstances of mortality categories (COMCATs)
component of InterVA-5 and compared these findings with
COMCAT analysis by physician review. Although physician

review and the InterVA-4 and InterVA-5 algorithms identified
the same most common maternal causes of death (obstetric
haemorrhage, non-obstetric complications, and hypertensive
disorders), we found poor agreement between physician review
and InterVA-5 on causes of death in individuals. The InterVA-5
COMCAT results emphasise the importance of quality and
continuity of care in facilities, which should be prioritised over
care-seeking and transport to health facilities. Our findings are
strengthened by a relatively large sample of maternal deaths, in
urban and rural settings in south Asia and sub-Saharan Africa,
and by use of data from communities with inadequate vital
registration systems and the greatest need for computerised
cause of death analysis of verbal autopsies.
Implications of all the available evidence
Our findings suggest that InterVA-4, and not InterVA-5, should
be used to ascertain maternal cause of death and assist in
reaching the WHO global standard of registering at least 50% of
deaths in communities. Further work is required to refine the
InterVA-5 cause of death and COMCAT analyses, and to identify
opportunities for improving outcomes in pregnant and postpartum women.

See Online for appendix
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In 2015, more than 300 000 women died from compli
cations during pregnancy or childbirth,1 mostly in lowincome and middle-income countries in sub-Saharan
Africa and south Asia. Although the global maternal
mortality rate (MMR) decreased during the Millennium
Development Goal era (from 330 deaths per 100 000 live
births in 2000 to 210 deaths per 100 000 in 2013),2
achieving the Sustainable Development Goal MMR of
fewer than 70 deaths per 100 000 livebirths by 2030 will
require action by communities, health-care providers,
and policy makers to address what underlies those deaths.
However, the burden, timing, and ante
cedents of
maternal death are incompletely understood, largely due
to a scarcity of comprehensive vital registration data.3
Various approaches have been developed to understand
the health-care journeys of women who have died during
pregnancy or post partum. Physician review is effective in
improving care and outcomes in settings where records
are good and death occurs in health facilities (eg, the UK
and Ireland4), but this approach is time consuming and
challenged by incomplete documentation of all deaths,
poor quality record keeping, and fear of retribution and
legal action against those involved in the care of women
who died. In settings where death registration is absent
or incomplete, an alternative approach to understanding
maternal deaths is verbal autopsy, a standardised
interview with the deceased’s next of kin that is designed
to explore the woman’s symptoms preceding her death,
and the circumstances in which her death occurred.
Computerised logarithmic probability models have been

developed to analyse verbal autopsy responses, to
establish reliable temporal and regional estimates of the
probable cause of maternal death, with results that were
similar to those obtained by physician review.5 The
interpreting verbal autopsies (InterVA) probabilistic
model was developed in 2012 by WHO, and is regularly
updated to optimise accuracy in specific circumstances,
such as maternal mortality.6
In particular, the hypertensive disorders of pregnancy
and pre-eclampsia are recognised to be a leading cause of
maternal mortality worldwide. The Community-Level
Interventions for Pre-eclampsia (CLIP) cluster random
ised controlled trials (RCTs) were designed to evaluate
whether community engagement and community-level
triage, transport, and treatment initiation could reduce
all-cause maternal (and perinatal) deaths and morbidity,
ascertained in the community, with maternal death
evaluated with the WHO verbal autopsy questionnaire
(2012 version).7 Although all-cause mortality in the CLIP
trials did not differ between intervention and control
clusters, in this secondary analysis we undertook
physician review and InterVA assessments of all maternal
deaths. Our aim was to compare agreement between
physician review and InterVA methodologies with regard
to cause of death and associated circumstances, to inform
efforts for improving care.

Methods

CLIP trials design and participants
The CLIP trials were independent cluster RCTs in urban
and rural India (12 clusters), Pakistan (20 clusters),
www.thelancet.com/lancetgh Vol 9 September 2021
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and Mozambique (12 clusters).7 Of the 44 clusters across
the three trials, 22 were intervention clusters and 22 were
control clusters.
In brief, pregnant women aged 15–49 years (12–49 years
in Mozambique) were enrolled after confirmation of
pregnancy and provision of informed consent, in India
(Nov 1, 2014, to Oct 31, 2016), Pakistan (Jan 1, 2015, to
Dec 31, 2016), and Mozambique (Feb 1, 2015, to
Feb 28, 2017). In the three CLIP trials, 69 330 pregnant
women were enrolled in 44 clusters (36 008 in the
22 intervention clusters and 33 322 in the 22 control
clusters), with successful follow-up for 61 988 (89%) preg
nancies.7 The intervention had two components:
community engagement and clinical assessment by
community health workers (mobile health-guided early
detection); and initial treatment (ie, oral methyldopa for
severe hypertension, and intramuscular magnesium
sulphate for severe pre-eclampsia) and referral to a
facility for hypertensive pregnancies. CLIP visits were
recommended at least every 4 weeks before birth, and on
post-partum days 3, 7, and 14. In control clusters, women
received usual care according to local practice, stated to
be blood pressure measurement and proteinuria testing
at each antenatal care contact.
The primary outcome was a composite of maternal,
fetal, and newborn death and severe morbidity; mortality
was measured up to 6 weeks after birth for the mother
and 28 days after birth for the neonate. Surveillance
data were collected by cross-sectional household
surveys (quarterly in Pakistan and every 6 months in
Mozambique) or from the Global Network’s Maternal
Newborn Health (MNH) Registry (in India).8 After
obtaining individual informed consent, data were
collected on baseline individual-level and household-level
information, antenatal care, and adverse outcomes up to
6 weeks after birth (for the mother) or 28 days after birth
(for the neonate). Data collection tools were modified
validated questionnaires translated into local languages.
All maternal deaths (and perinatal deaths and maternal
and neonatal morbidities) were confirmed by outcome
adjudication of trial surveillance data, by in-country teams
(primarily doctors) familiar with local language (for
interpretation of narratives, if available) and context, but
who were masked to cluster type and uninvolved in the
women’s care. An independent trained team administered
the WHO 2012 verbal autopsy9 as soon as possible after
maternal death, by visiting the deceased woman’s
household and interviewing a next of kin about health
problems, symptoms, and circumstances in the time
leading up to the woman’s death. In India, Mozambique,
and some districts in Pakistan (those with the staffing
capacity), interviewees asked next of kin at the end of the
structured interview to describe in their own words what
had happened to their loved one; these narratives were
translated into English and used in physician review.
Data were entered on Android devices and de-identified,
and transferred regularly to the University of British
www.thelancet.com/lancetgh Vol 9 September 2021

Columbia (UBC) CLIP coordinating centre (Vancouver,
BC, Canada). Data were uploaded monthly onto the
Research Electronic Data Capture server (version 5;
Vanderbilt University, Nashville, TN, USA). Data
management protocols ensured security (encryption),
tracking (user identification numbers and audit trails),
and synchronisation between devices within the cluster
and with the Research Electronic Data Capture server.

Procedures
For this secondary analysis, we included women who
died in any of the 44 intervention or control clusters, as
our primary interest was in measuring the causes and
circumstances of maternal death.
In a central process at UBC, for all maternal deaths,
two doctors independently reviewed all trial surveillance
data and verbal autopsies, and community health workerled visit data for intervention clusters. The reviewers’
experience was in maternal–fetal medicine (PvD),
obstetrics (AMA or KA), and obstetric medicine (LAM;
also an assessor and chapter writer for the UK and
Ireland Confidential Enquiries into Maternal Death and
Morbidity). The reviewers were masked to the InterVAgenerated cause of death until the cause of death
from physician review was established. Cause of death
was classified according to the nine categories of the
WHO International Classification of Diseases-Maternal
Mortality (ICD-MM).10 Disagreement was resolved by
consensus, involving a third doctor, if necessary. If
consensus could not be reached, cause of death was that
assigned by two reviewers who agreed. If no two agreed,
cause of death was considered undetermined. In India,
supplementary data from the MNH Registry was used to
facilitate the physician review of circumstances of death.
For all maternal deaths, the 2012 WHO verbal autopsy,
a question
naire specifically designed by WHO for
automated processing on the basis of previous validation
between physician review and causes of death, was
analysed by the InterVA suite of computer models
(versions 4 and 5) to generate cause of death categorised
according to the ICD-MM. InterVA-4 was available at the
time that the CLIP trials were planned and executed;
InterVA-5 was included when released during the trials to
provide the most useful comparisons. The a priori
probabilities for each of malaria and HIV were set as high
for Mozambique and low for India and Pakistan. If the
InterVA cause of death output for a woman gave more
than one possible cause of death, the one with the highest
probability was used for comparison with cause of death
assigned by physician review.
InterVA-5 was published in 2018, to harmonise with
the new WHO verbal autopsy 2016 standard, following
updates to the 2012 WHO verbal autopsy based on the
processing of more than 650 000 verbal autopsy reports
with InterVA-4.6 Of relevance to this analysis, InterVA-5
incorporates a novel circumstances of mortality
categories (COMCAT) analysis,11 with circumstances
e1244
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Panel: Circumstances of mortality categories (COMCAT)
definitions11
• Traditions: traditional practices or beliefs influenced
health seeking behaviour and the pathway to death
• Emergencies: sudden, urgent, or unexpected conditions
leading to death, which probably precluded life-saving
actions
• Recognition: poor recognition or awareness of serious
disease, such as symptoms or severity, had a negative
influence on health seeking behaviour
• Resources: inability to mobilise and use resources, such as
material, transport, or financial, that hindered access to
health care
• Health systems: problems in getting health care despite
accessing health facilities, such as problems related to
admissions, treatments, and medications
• Inevitability: death occurred in circumstances that could
not reasonably have been averted, such as in the context
of old age or recognised terminal conditions
• Multiple: a combination of the other COMCATs affected
the pathway to death, with no single factor predominant
at a likelihood of more than 50%

categorised as traditions, emergencies, recognition,
resources, health systems, inevitability, and multiple11
(definitions provided in the panel). In India, where
additional information was provided by MNH Registry
data, clinical care was evaluated as part of the physician
review process to ascertain whether improvements in
care could be identified that might have made a difference
to survival outcome (as opposed to good care, with any
improvements in care identified as unlikely to have made
a difference to outcome), as undertaken in the UK and
Ireland Confidential Enquiries into Maternal Deaths and
Morbidity;4 the results informed a COMCAT assessment
by physician review, in which inevitability was the
classification assigned when no improvements in care
were identified. We present the InterVA-5 COMCAT
assessment of all three trials and physician reviewgenerated assessments of the India trial data. A formal
qualitative analysis of verbal autopsy narratives from all
three countries is being under
taken and a separate
publication is planned.

Statistical analysis
Descriptive analyses were undertaken, overall and by
country, to evaluate MMR (maternal deaths per 100 000
livebirths) and maternal death rate (MDR, as the
number of maternal deaths per 100 000 identified
pregnancies); maternal and pregnancy characteristics
at enrolment (baseline) and associated pregnancy
outcomes (from trial surveillance); the details of
maternal deaths (from trial surveillance and verbal
autopsy forms); and causes of death and, for India only,
COMCATs, assigned by physician review, InterVA-4, and
e1245

InterVA-5. For MMR and MDR we calculated 95% Waldtype CIs.
InterVA-4 assignment of hypertensive disorders of
pregnancy as a cause of death, as a secondary interest of
our analysis, was compared between intervention and
control clusters, with multilevel modelling and adjusted
odds ratios (ORs) with 95% CIs (fixed effects for maternal
age, parity [nulliparous vs parous], and basic education,
and random effects for country and cluster). Basic
education was defined as primary education (country
specific) and determined from self-reported number of
years of school attended. Mortality was also compared
between intervention and control clusters with similar
adjusted models (excluding random effects for cluster).
The maternal causes of death assigned by physician
review, InterVA-4, and InterVA-5 were compared
for overall deaths and by country, according to a
three-category classification (as per the ICD-MM) of
direct maternal cause, indirect maternal cause, or
undetermined; the nine-category ICD-MM classification;
and a seven-category COMCAT classification (India
data only). Agreement was estimated with Cohen’s κ
coefficient with 95% CIs; agreement was considered
poor for κ values less than 0·40, fair to good for κ values
in the range 0·40–0·75, and excellent for κ values greater
than 0·75.12 Analyses were done with R programming
software (version 3.3.2).
The CLIP trials were approved by the UBC research
ethics board (H12-03497), and within each country
(KLE University [MDC/IECHSR/2013-14/A and ICMR
5/7/859/12-RHN], India; Aga Khan University
[2590-Obs-ERC-13], Pakistan; and Centro de Investigação
em Saúde da Manhiça [CIBS-CISM/038/14] and
Mozambique National Bioethic Committee [219/
CNBS/13], Mozambique). The CONSORT and STROBE
checklists are in the appendix (pp 3–11).

Role of the funding source
The funder of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of
the report.

Results
Among the 61 988 pregnancies with successful follow-up
in the CLIP trials, 143 maternal deaths were reported
(16 deaths in India, 105 in Pakistan, and 22 in Mozambique).
For 127 (89%) deaths, data were acquired solely in women’s
communities rather than from facilities. The probability of
maternal death did not differ in the intervention clusters
(77 deaths) versus control clusters (66 deaths), adjusted for
trial setting (country and cluster) and baseline maternal
characteristics (age, parity, and basic education; adjusted
OR 1·05 [95% CI 0·67–1·64], p=0·84).
From the 143 maternal deaths, we calculated an
overall MMR of 253 (95% CI 212–295) per 100 000 live
births, and an MDR of 231 (95% CI 193–268) per
100 000 identified pregnancies, with the lowest MDR
www.thelancet.com/lancetgh Vol 9 September 2021
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in India (123 [63–183] per 100 000) and the highest in
Pakistan (293 [237–349] per 100 000; table 1).
Women who died were young, ranging in median age
from 21·5 years (IQR 20·0–24·0) in India to 30·0 years
(25·0–32·0) in Pakistan (table 1). Most women were
parous, particularly in Pakistan. A basic level of education
was reported by most women in India, more than half
in Mozambique, and a minority in Pakistan. All women
were married in India and Pakistan, but only half
were married in Mozambique. Generally, women who
died in India had attended at least one antenatal care
appointment in the first trimester (gestational weeks
1–12; ten [63%] of 16 women) and most had received at
least four routine antenatal care visits. In Pakistan and
Mozambique, women who died had attended their first
appointment at a median of 21–22 weeks’ gestation
(middle of their second trimester), and only about a third
had received four or more antenatal care visits. Few
women had attended their first appointment in the first
trimester (ten [10%] of 105 women in Pakistan and two
[9%] of 22 in Mozambique).
Details of maternal deaths were recorded by verbal
autopsy as early as one week (median 8 days [IQR 3–21])
after death in India, to more than 5 months (158 days
[47–252]) after death in Mozambique (table 1). The verbal
autopsy respondent differed by country, and was most
often the husband (widower) in India and the husband’s
parents (parents-in-law) in Pakistan, with a wide variety of
respondents in Mozambique.
The frequency with which women had antecedent
maternal morbidity varied by country. Most of the
women who died in India had a documented serious
end-organ complication, followed by around a third of
the women in Pakistan, and about a quarter of the
women in Mozambique (table 1). In addition, morbidity
was defined by having received a potentially life-saving
intervention, typically cardiopulmonary resuscitation or
blood transfusion.
Most women died in a health facility, although about a
third died in transit to a facility in India (table 1). About a
quarter of women died antepartum and, by definition,
undelivered. Based on median gestational age at death in
each country, antepartum deaths typically occurred early
in the third trimester (India), late preterm (Pakistan), or
at term (Mozambique). About three-quarters of women
died post partum, either after late preterm delivery
(Mozambique) or at term (India and Pakistan). These
women most frequently died within 24 h post partum,
although many died more than 1 week after birth. Mode
of delivery was usually vaginal and at a health facility.
Among all women who died, stillbirth was frequent,
particularly in Pakistan and Mozambique, and a fifth of
babies born alive subsequently died, usually within the
first 7 days after birth.
Cause of death assigned by physician review was
informed by next-of-kin narratives (in addition to the
structured verbal autopsy interview) for all deaths in
www.thelancet.com/lancetgh Vol 9 September 2021

India and Mozambique, and 55 (52%) of 105 deaths
in Pakistan. In the physician review and InterVA
assignment of total maternal deaths (n=143) as having
direct maternal cause, indirect maternal cause, or unde
termined, deaths were most often attributed to direct
maternal causes (table 2). This was true overall and
by country, with the exception of physician review
assignments in Mozambique, where slightly more
than half of deaths (12 [55%] of 22) were attributed to
indirect maternal causes. Expectedly, these deaths in
Mozambique were attributed by physician review to
Total
(N=143)

India
(N=16)

Pakistan
(N=105)

Mozambique
(N=22)

Incidence of maternal deaths
MMR, deaths per 100 000
livebirths

253 (212–295)

145 (74–216)

319 (259–381)

174 (102–247)

MDR, deaths per 100 000
identified pregnancies

231 (193–268)

123 (63–183)

293 (237–349)

167 (97–237)

Maternal and pregnancy characteristics
Maternal age, years

28·0 (24·5–32·0)

Nulliparous

32 (22%)

Missing

6 (4%)

Basic education
Married
Gestational age at
enrolment, weeks
Number of routine
antenatal care visits

21·5 (20·0–24·0)
7 (44%)
0

30·0 (25·0–32·0)
19 (18%)
6 (6%)

37 (26%)

12 (75%)

13 (12%)

132 (92%)

16 (100%)

105 (100%)

19·8 (14·6–26·4)
3 (1–5)

11·2 (8·5–13·5)

21·2 (15·9–26·8)

26·5 (22·3–34·0)
6 (27%)
0
12 (55%)
11 (50%)
21·7 (17·5–30·5)

5 (4–6)

2 (1–4)

0 (0–4)

At least one visit

110 (77%)

16 (100%)

84 (80%)

10 (45%)

At least four visits

55 (38%)

13 (81%)

35 (33%)

7 (32%)

Details of maternal deaths
Latency between death and
verbal autopsy completion,
days

62 (33–103)

8 (3–21)

64 (35–100)

158 (47–252)

Respondent for the verbal autopsy
Husband

21 (15%)

8 (50%)

10 (10%)

3 (14%)

Sibling (sister or brother)

22 (15%)

0

19 (18%)

3 (14%)

Sister in-law or
brother-in-law

25 (17%)

2 (13%)

22 (21%)

1 (5%)

Mother or father

13 (9%)

1 (6%)

8 (8%)

4 (18%)

Mother in-law or
father-in-law

47 (33%)

3 (19%)

41 (39%)*

3 (14%)

Other (requested to
specify)

15 (10%)

2 (13%)†

5 (5%)*

8 (36%)‡

38 (36%)

6 (27%)

Antecedent maternal morbidities documented
One or more serious endorgan complications

56 (39%)

12 (75%)

Seizure

11 (8%)

5 (31%)

5 (5%)

1 (5%)

Stroke

14 (10%)

6 (38%)

6 (6%)

2 (9%)

Coma

10 (7%)

1 (6%)

6 (6%)

3 (14%)

Antepartum
haemorrhage

11 (8%)

1 (6%)

9 (9%)

1 (5%)

5 (3%)

2 (13%)

2 (2%)

1 (5%)

2 (13%)

8 (8%)

3 (14%)

0

0

0

Disseminated
intravascular coagulation
Sepsis
Fistula

13 (9%)
0

(Table 1 continues on next page)
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Total
(N=143)

India
(N=16)

Pakistan
(N=105)

Mozambique
(N=22)

(Continued from previous page)
Life-saving interventions
given during pregnancy
Cardiopulmonary
resuscitation

40 (28%)

9 (56%)

28 (27%)

3 (14%)

24 (17%)

3 (19%)

19 (18%)

2 (9%)

Dialysis

3 (2%)

1 (6%)

2 (2%)

Mechanical ventilation

8 (6%)

3 (19%)

3 (3%)

22 (15%)

6 (38%)

16 (15%)

5 (3%)

2 (13%)

2 (2%)

1 (5%)

0

14 (13%)

2 (9%)
4 (18%)

Blood transfusion
Intervention for major
post-partum
haemorrhage
Missing

16 (11%)

0
2 (9%)
0

Location of death§
Home

24 (17%)

1 (6%)

19 (18%)

In transit to facility

16 (11%)

5 (31%)

10 (10%)

1 (5%)

103 (72%)

10 (63%)

76 (72%)

17 (77%)

Health facility
Timing of death§
Antepartum

38 (27%)

5 (31%)

28 (27%)

5 (23%)

Post partum

105 (73%)

11 (69%)

77 (73%)

17 (77%)

30·0 (28·5–33·5)

35·5 (32·3–39·0)

38·0 (28·0–39·0)

37·0 (31·0–41·0)

38·0 (34·5–40·0)

35·0 (34·5–41·0)

For women who died antepartum
Gestational age at death,
weeks§

34·5 (30·8–38·3)

For women who died post partum
Gestational age at delivery,
weeks

38·0 (34·0–40·0)

Timing of death post partum§
<24 h

59/105 (56%)

6/11 (55%)

46/77 (60%)

7/17 (41%)

1–6 days

17/105 (16%)

2/11 (18%)

12/77 (16%)

3/17 (18%)

1–6 weeks

24/105 (23%)

3/11 (27%)

15/77 (19%)

6/17 (35%)

4/77 (5%)

1/17 (6%)

Missing

5/105 (5%)

0

Mode of delivery§
Caesarean

38/105 (36%)

4/11 (36%)

26/77 (34%)

8/17 (47%)

Vaginal birth

67/105 (64%)

7/11 (64%)

51/77 (66%)

9/17 (53%)

Location of birth§
Home

16/105 (15%)

1/11 (9%)

11/77 (14%)

4/17 (24%)

Health facility

89/105 (85%)

10/11 (91%)

66/77 (86%)

13/17 (76%)

In transit

0

0

0

0

Pregnancy outcome for all women
Stillbirth

28 (20%)

1 (6%)

20 (19%)

7 (32%)

Early neonatal death
(≤7 days after birth)

19 (13%)

2 (13%)

14 (13%)

3 (14%)

Late neonatal death
(>7 days after birth)

4 (3%)

3 (3%)

1 (5%)

Survived follow-up

92 (64%)

68 (65%)

11 (50%)

0
13 (81%)

Data are n (%), n/N (%), or median (IQR); values in parentheses for MMR and MDR are 95% CIs. Percentages might not
always add to 100% due to rounding. CLIP=Community-Level Interventions for Pre-eclampsia. MMR=maternal mortality
ratio. MDR=maternal death rate. *The other respondents in Pakistan were aunt (n=3), grandparent (n=1), or child (n=1); all
of the mother-in-law or father-in-law respondents were mothers-in-law. †The other respondents in India were
grandparent (n=2). ‡The other respondents in Mozambique were aunt (n=1), child (n=2), child-in-law (n=1), grandparent
(n=1), a neighbour (n=1), or a so-called rival (co-spouse or other sexual partner of the father of the pregnancy; n=2).
§These data were taken from verbal autopsies as the information was not available from trial surveillance reports.

Table 1: Baseline maternal characteristics, CLIP intervention, and pregnancy outcomes for 143 maternal
deaths in the CLIP trials
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non-obstetric complications among the nine categories
of the ICD-MM, related primarily to infectious
diseases (n=9; most commonly HIV [n=2] and
malaria [n=4]), or cardiac disease (n=3; appendix
pp 12–14). For the three-category classification of
maternal cause of death (direct maternal, indirect
maternal, or undetermined), we observed fair to good
agreement between physician review and either
InterVA-4 (κ=0·56 [95% CI 0·43–0·66]) or InterVA-5
(κ=0·44 [0·30–0·57]), and between InterVA-4 and
InterVA-5 (κ=0·72 [0·60–0·84]; table 3).
In the ICD-MM classification of specific cause of death,
the three top causes for overall deaths were the same by
physician review, InterVA-4, and InterVA-5 (figure). These
were obstetric haemorrhage (ICD-MM category 3),
followed by non-obstetric compli
cations (ICD-MM
category 7), and hypertensive disorders (ICD-MM
category 2). Hypertensive disorders as a cause of death
(by InterVA-4) did not differ in the intervention clusters
(13 [17%] of 77 deaths) versus the control clusters (12 [18%]
of 66 deaths; OR 0·93 [95% CI 0·46–1·89]; p=0·84).
Attribution to obstetric haemorrhage varied more
between methods (physician review, 38 [27%] deaths;
InterVA-4, 69 [48%] deaths; and InterVA-5, 82 [57%]
deaths) than did attribution to non-obstetric causes
(physician review, 39 [27%] deaths; InterVA-4, 37 [26%]
deaths; and InterVA-5, 28 [20%] deaths), or hypertensive
disorders (physician review, 23 [16%] deaths; InterVA-4,
25 [17%] deaths; and InterVA-5, 24 [17%] deaths; table 2,
figure). Few maternal deaths (<5% and often <1%)
were attributed to pregnancy-related infection, abortive
outcomes, unanticipated complications of management,
or coincidental causes (figure, table 2). A small proportion
of all maternal causes of death were unknown or
undetermined (16 [11%] deaths assigned by physician
review, six [4%] by InterVA-4, and four [3%] by InterVA-5).
Agreement between the cause of death methods for the
nine ICD-MM categories was fair for physician review
versus InterVA-4, poor for physician review versus
InterVA-5, and good for InterVA-4 versus InterVA-5
(table 3); similar results were observed by country
(appendix p 15). Physician review identified that in cases
of shock, women could be assigned by InterVA as having
obstetric haemorrhage without any evidence of bleeding
(31 ([22%] and 44 [31%] additional cases of obstetric
haemorrhage by InterVA-4 and InterVA-5, respectively).
By physician review, these cases were distributed between
other causes of death excluding hypertension.
For circumstances of death, InterVA-5 most commonly
assigned the COMCAT classifications of emergencies
(68 [48%] of 143 deaths) and health systems (62 [43%]
deaths); whereas, few maternal deaths were assigned
to traditions, recognition, or multiple circumstances.
By physician review (possible only in India), health
systems (seven [44%] of 16 deaths) and inevitability
(five [31%] deaths) were the most common circumstances
of death (table 2). Agreement between physician review
www.thelancet.com/lancetgh Vol 9 September 2021
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Physician
review

InterVA-4 InterVA-5

Three-category classification (ICD-MM)

Physician
review

InterVA-4 InterVA-5

(Continued from previous column)

Direct maternal cause

88 (62%)

100 (70%)

110 (77%)

COMCAT§

Indirect maternal cause

39 (27%)

37 (26%)

28 (20%)

Traditions

0¶

NA

1/143 (1%)

Undetermined cause

16 (11%)

6 (4%)

5 (3%)

Emergencies

2/16 (13%)¶

NA

68/143 (48%)

Recognition

2/16 (13%)¶

NA

1/143 (1%)

0

1 (1%)

Resources

0

NA

9/143 (6%)
62/143 (43%)

Nine-category classification (ICD-MM)
(1) Abortive outcomes

1 (1%)

(2) Hypertensive disorders

23 (16%)

25 (17%)

24 (17%)

Health systems

7/16 (44%)¶

NA

(3) Obstetric haemorrhage

38 (27%)

69 (48%)

82 (57%)

Inevitability

5/16 (31%)¶

NA

0

6 (4%)

2 (1%)

0

Multiple

0¶

NA

2/143 (1%)

16 (11%)

4 (3%)

3 (2%)

(4) Pregnancy-related
infection
(5) Other obstetric
complications
Venous
thromboembolism

8/16

0

0

Uterine inversion or
rupture

2/16

0

1/3
1/3

Suicide

2/16

1/4

Obstructed labour

0

3/4

1/3

Other*

4/16

0

0

4 (3%)

0

0

(6) Unanticipated
complications of clinical
management
(7) Non-obstetric
complications
Infectious disease

39 (27%)

37 (26%)

28 (20%)

26/39

28/37

20/28

Data are numbers of women and percentages. Percentages might not always add to
100% due to rounding. COMCAT=circumstances of mortality categories.
ICD-MM=International Classification of Diseases-Maternal Mortality.
InterVA=interpreting verbal autopsy. NA=not applicable. *Other obstetric
complications were amniotic fluid embolism (n=1), peripartum cardiomyopathy
(n=1), complications of intrauterine fetal demise (n=1), and disseminated
intravascular coagulation (n=1). †Other infections were meningitis (n=2), tetanus
(n=1), hepatitis (n=1), measles (n=1), and infections not otherwise specified (n=3).
‡Other non-obstetric causes were stroke (n=1), breast neoplasm (n=1), asthma
(n=2), and chronic obstructive pulmonary disease (n=2). §COMCAT definitions are
provided in the panel. ¶India only.

Table 2: Maternal causes of death as determined by InterVA and
physician review for overall deaths (N=143)

κ (95% CI)*

Respiratory

9

11

9

Three-category classification (ICD-MM)

Gastrointestinal

3

1

0

Physician review versus InterVA-4

0·56 (0·43–0·66)
0·44 (0·30–0·57)
0·72 (0·60–0·84)

Malaria

5

4

1

Physician review versus InterVA-5

HIV

2

8

7

InterVA-4 versus InterVA-5

Tuberculosis

2

3

1

Nine-category classification (ICD-MM)

1

2

Physician review versus InterVA-4

0·48 (0·38–0·58)

3/37

4/28

Physician review versus InterVA-5

0·36 (0·27–0·46)

InterVA-4 versus InterVA-5

0·69 (0·59–0·79)

Other†
Cardiac disease

5
10/39

Liver disease

2/39

3/37

2/28

Other‡

1/39

3/37

2/28

6 (4%)

4 (3%)

0

1 (1%)

(8) Unknown or
undetermined
(9) Coincidental causes

16 (11%)
0

(Table 2 continues in next column)

and InterVA-5 for COMCAT (India data only) was poor
(κ=0·04 [95% CI 0·00–0·15).
During physician review of maternal deaths in India,
distinguishing between the COMCATs of emergencies
and inevitability was difficult without direct review of
health records to understand quality of care. Physician
review of summary data in the MNH Registry identified
six of the 16 maternal deaths for which improvements
in care might have made a difference to outcome. Five
were classified under health systems circumstances,
related to suboptimal facility care (n=3 for hypertensive
pregnancies, either failure to administer antihyper
tensives for severe hypertension [n=2] or to initiate birth
for pre-eclampsia at term [n=1]; and n=2 for obstetric
haemorrhage when no intervention for the haemorrhage
www.thelancet.com/lancetgh Vol 9 September 2021

ICD-MM=International Classification of Diseases-Maternal Mortality.
InterVA=interpreting verbal autopsy. *A κ statistic of less than 0·40 was
considered poor agreement, 0·40–0·75 fair to good agreement, and greater
than 0·75 excellent agreement.

Table 3: Cohen’s κ statistics for agreement between methods of
assigned maternal cause of death (N=143)

was offered). In one case of cardiovascular collapse in
transit to facility (deemed an emergency), no cardio
pulmonary resuscitation was attempted.
Although quality of care could not be assessed
formally in Pakistan or Mozambique due to the scarcity
of detailed information from health facilities, the
narratives from next of kin did highlight some of the
health systems failures identified by the InterVA-5
COMCAT analysis of deaths overall, and by physician
review in India. Reviewers noted several instances in
which the woman’s relatives were asked to arrange blood
products for transfusion, even during resuscitation for
obstetric haemorrhage. In addition, reviewers noted
several instances in which the woman was ill and
attended a health facility (private or public), but they
e1248
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International Classification of Diseases-Maternal Mortality category
(1) Abortive outcomes
(2) Hypertensive disorders
(4) Pregnancy-related infection
(5) Other obstetric complications
(7) Non-obstetric complications
(8) Unknown or undetermined
100
16

1
4

6

90

28

37

80

Proportion of deaths (%)

60
50

1

3

6
8

3

1
12

16

40
38

1

20
10
0

23

8
4
1

63
53

10

9

5
30

19

5

6

69

1

12

1
82

3
13

4

4

6

2

2

25

4

4
2

3

1

4

3

39
70

1

(3) Obstetric haemorrhage
(6) Unanticpated complications of management
(9) Coincidental causes

29

10

4
23

25

24

1
Physician
review

InterVA-4

Total

2

1

1

InterVA-5

Physician
review

4

4

2
InterVA-4

InterVA-5

India

2

2

Physician
review

InterVA-4

19

19

18
1

Mozambique

InterVA-5

Physician
review

InterVA-4

InterVA-5

Pakistan

Figure: Maternal causes of death according to physician review, InterVA-4, and InterVA-5 (N=143)
Number of women are presented for each cause. InterVA=interpreting verbal autopsy.

were deemed too ill for that facility, refused assessment
or treatment, and advised to seek help at another facility,
without transport assistance. Publication of the complete
verbal autopsy analysis is planned.

Discussion
For the 143 maternal deaths (MMR 253 [95% CI 212–295]
per 100 000 livebirths) in the CLIP trials in India, Pakistan,
and Mozambique, we found that physician review and
the computer algorithms of InterVA-4 and InterVA-5 had
high public health equivalence, revealing the same top
three maternal causes of death: obstetric haemorrhage,
non-obstetric causes, and hypertensive disorders of
pregnancy. However, attribution to each cause of death
varied by method; of the three methods, InterVA-5 was
most likely to assign obstetric haemorrhage and least
likely to assign non-obstetric causes as a cause of death.
Agreement for physician review versus InterVA-4 was
better than for physician review versus InterVA-5. Both
the physician review and InterVA-5 COMCAT analyses
identified health systems circumstances as underlying
more than 40% of maternal deaths, but physician review
also commonly identified inevitability of circumstance,
whereas emergency circum
stances were identified the
most by InterVA-5.
Our findings suggest that for public health planning
and policy aimed at reducing maternal death, InterVA-4
is a reasonable alternative to physician review; how
ever, obstetric haemorrhage might be over-represented,
e1249

particularly if women show signs of shock without
evidence of bleeding. Physician review was informed
by next-of-kin narratives; developments in software
interpretation of free text might lead to further
improvements in InterVA algorithm performance.
InterVA-5 performed poorly for maternal cause of death,
particularly in identifying non-obstetric causes. This
finding might be increasingly relevant as countries
move through stages of obstetric transition and indirect
causes of death increase in frequency.13
The novel InterVA-5 COMCAT analysis of maternal
deaths did not highlight delays in care (in obstetric
care-seeking or in reaching an appropriate obstetric
facility, commonly referred to as first and second
delays, respectively14); traditions, recognition, and
resources were indicated to be unimportant for most
women in the events leading to their deaths. Furthermore,
few women were identified to have multiple underly
ing circumstances. These insights emphasise the
importance of delays in receiving quality care (the socalled third delay14), especially in continuity of care, as
being modifiable contributors to maternal deaths; if
addressed, outcomes should improve. Additionally, our
findings suggest that for maternal death specifically,
further work might be required to distinguish between
emergencies (for which outcomes would be avoidable
only through prevention, rather than treat
ment) and
inevitability (particularly for women offered good care
who, nevertheless, did not avoid death).
www.thelancet.com/lancetgh Vol 9 September 2021
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To our knowledge, this study provides the first
comparison of maternal causes of death by physician
review, InterVA-4, and InterVA-5, and of COMCAT
analyses by physician review and InterVA-5. One
published comparison of InterVA-4 and InterVA-5
focused on HIV and excluded maternal deaths.15 A
second publication evaluated the causes of all deaths in
adults and children, comparing physician-assigned cause
of death at tertiary hospitals involved in final care with
InterVA-4 and InterVA-5, which found high concordance
(eg, InterVA-5 correlation coefficient of 0·86 [0·79–0·93]
for adults).6
InterVA-4 has been compared with physician review for
deaths in general16–19 and for maternal death specifically.20
In Africa and Asia among adults or the general
population, concordance between physician review and
InterVA-4 has been variably reported, as high (≥80%)17,18
or not.16,19,21 Among 86 maternal deaths analysed at the
health-facility level in Malawi, fair to good agreement
was reported between an expert physician review panel
and InterVA-4 for ICD-MM categories 1–7 (Cohen’s
κ=0·66), although the expert physician review panel
assigned cause of death as unspecified more often than
both InterVA-4 and InterVA-5.20 In that analysis, the
top four assigned direct maternal causes of death for
expert physician review and InterVA-4 were obstetric
haemorrhage (34% vs 30%), pregnancy-related infections
(14% vs 17%), hypertensive disorders (12% vs 16%), and
pregnancy with abortive outcomes (14% vs 15%). Similar
to the Malawi study, agreement between physician review
and InterVA-4 in our analysis was fair to good, and
physician review identified unknown or indeterminate
cause of death more frequently than InterVA-4; however,
our κ value was lower (0·48 vs 0·6620), which might have
been due to our assessment of deaths in three countries
(rather than one), or that most of our data (89%) for
physician review was from the community (rather than
from a single health facility).
Strengths of our study include a relatively large sample
of deaths, representation of urban and rural settings
in south Asia and sub-Saharan Africa, and use of data
from communities, making our results generalisable to
where there is the greatest need for computerised cause
of death analysis of verbal autopsies. We compared
physician review and both InterVA-4 and InterVA-5
computerised algorithms for cause of death and
COMCAT.
Limitations include those of the verbal autopsy itself,
which has questions lacking clarity of purpose, such
as the needed or received designation for medication,
rather than needed but unavailable or not received,
meaning the possibility for improvements in care cannot
be determined. Physician review was done by a central
team familiar with local contexts, but from none of the
CLIP countries. Social factors were considered in this
review; however, a social autopsy or diagnosis was not
done, based on availability of resources. A verbal autopsy
www.thelancet.com/lancetgh Vol 9 September 2021

narrative was available for about two-thirds of maternal
deaths in Pakistan (65% of deaths overall), and narratives
in Mozambique were limited in detail. Although CLIP
data forms were available for physician review, the lack of
comprehensive, detailed verbal autopsy narratives for all
deaths might have compromised cause of death
assignment in Pakistan and Mozambique, where quality
of care could not be evaluated. The lack of detailed verbal
autopsy reports was compounded by limited detail in
women’s health records in these settings. The betweencountry differences in respondents and verbal autopsy
timing might have had an effect on responses, but the
top causes of death and proportion of direct maternal
deaths were similar; we had insufficient power to
examine these differences by country. Finally, we were
not able to identify how weights in the probabilistic
model for InterVA-5 differed from InterVA-4, because
neither demographic health survey data nor health
facility records were available to us.
Our findings suggest that InterVA-4, not InterVA-5,
should be used to ascertain maternal cause of death,
particularly given the global rise in non-obstetric maternal
deaths,22 and to assist in reaching WHO’s global standard
of registering at least 50% of deaths in communities.23
Further work is required to refine InterVA-5 regarding
assignment of obstetric haemorrhage and non-obstetric
causes of death and COMCAT analysis, and to identify
opportunities for improving maternal outcomes.
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